Experimental treatment for Niemann-Pick disease appears safe
Por um escritor misterioso
Descrição
An experimental drug has appeared to slow the progression of Niemann-Pick disease the drug 2-hydroxypropyl-beta-cyclodextrin is being tested
Correlation of age of onset and clinical severity in Niemann–Pick disease type C1 with lysosomal abnormalities and gene expression
5 Most Promising Companies offering hope to patients with Niemann-Pick Type C
Investigation of 2-Hydroxypropyl-β-Cyclodextrin Treatment in a Neuronal-Like Cell Model of Niemann–Pick Type C Using Quantitative Proteomics
PDF) Efficacy and safety of arimoclomol in Niemann–Pick disease type C: Results from a double‐blind, randomized, placebo‐controlled, multinational phase 2/3 trial of a novel treatment
Niemann-Pick Disease, A Pipeline Analysis Report 2018, Technavio
Familial Hypercholesterolemia: From Clinical Suspicion to Novel Treatments
Full article: Current advancements in therapy for Niemann-Pick disease: progress and pitfalls
Generation of Niemann– Pick disease type C1 (NPC1) induced pluripotent
Lithium ameliorates Niemann-Pick C1 disease phenotypes by impeding STING/SREBP2 activation - ScienceDirect
Niemann-Pick disease - News, Articles etc. - European Pharmaceutical Review
Niemann-Pick Disease, Type B disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials
de
por adulto (o preço varia de acordo com o tamanho do grupo)
